Bluesky Facebook Reddit Email

Metformin & leucine prevent cellular senescence & proteostasis disruption

Researchers found that metformin + leucine (MET+LEU) treatment prevents myotube atrophy by reversing cellular senescence and improving proteostasis. The study used C2C12 myoblasts, aged mouse single myofibers, and human primary myotubes to demonstrate MET+LEU's skeletal muscle cell-autonomous properties.

Researchers awarded $2.1M to study muscles

The UMass Lowell-led team aims to understand how proteins affect biting function in animals, with potential applications in treating diseases like muscular dystrophy. The research will involve studying molecular properties of myosin, a fibrous motor protein, and its impact on muscle force and velocity.

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Spinal anesthesia linked to higher painkiller use in hip fracture patients

A recent study published in Annals of Internal Medicine found that patients who underwent spinal anesthesia for hip fracture surgery experienced more pain and were more likely to use prescription painkillers compared to those who received general anesthesia. The researchers hope to improve pain care by increasing the use of peripheral ...

Malnutrition links kidney disease, weaker muscles

A study published in Frontiers in Nutrition found that malnutrition contributes to sarcopenia in hemodialysis patients, characterized by muscle mass, strength, and function losses. The Nutrition Risk Index (NRI) is a simple and convenient metric developed in Japan, which shows significant relationships between NRI score and sarcopenia,...

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Why do we lose muscle mass when physical activity levels decline?

Researchers at Kobe University discover that immobilization induces loss of muscle mass by disrupting calcium levels and triggering the KLF15-IL-6 pathway. This finding may lead to the development of a treatment for muscle loss, known as sarcopenia, which affects aging societies.